Region II and NSH are joining forces!
June 13-14, NSH and the states of Region II will be kicking off summer in Baltimore for the 7th Annual Summer Symposium. This event offers two full days of workshops, general sessions and an exhibit hall. This event will take place in the beautiful Inner Harbor which offers restaurants, shopping and a great night life. Learn more.
The results of the 2014 NSH Scholarship Awards are in! This year NSH was able to award seven $500 student scholarships. Congratulations to all of the winners and thank you to all of our generous sponsors.
With budgets being tight at both work and home, we know you are looking for a cost effective way to attend this year's event. We have provided some sample schedules to help you plan an affordable trip to Austin, this August. These schedules offer you a chance to earn 7 to 12.5 contact hours and ranging from only $170 - $220 for the entire conference. Whether it be a weekend trip or a full week, we have options for you with our al la carte registration. Click here for more information.
Clinicians are ordering more comprehensive gene tests to look for mutations carrying higher risks of hereditary cancer. These multigene panels are raising questions about the scope of information being collected as the science and the industry move toward increasingly advanced sequencing.
Pathologists and clinical laboratory managers can expect that physicians will want to incorporate digital remote patient monitoring into their clinical practices.
High resolution X-ray crystallography is an imaging technique in which X-ray beams are shot through purified, crystallized proteins. The beam scatters in different directions, allowing scientists to construct a detailed, 3-D model of the crystallized protein's molecular structure. Measuring the intensities and angles of the diffracted beams reveals the position of each atom in the protein.
Researchers report that a new blood test could help doctors find pancreatic cancer at an earlier stage, potentially improving a patient's chances of survival. A set of four "markers" — or signs — in the blood identified cases of pancreatic cancer nine out of 10 times, sorting malignancies from other diseases like chronic pancreatitis or pancreatic cysts.
A major step forward in our understanding of how enzymes "edit" genes has been made by an international team of researchers, paving the way for correcting genetic diseases in patients. Researchers have observed the process by which a class of enzymes called CRISPR — pronounced "crisper" — bind and alter the structure of DNA. The results provide a vital piece of the puzzle if these genome editing tools are ultimately going to be used to correct genetic diseases in humans.
The Spanish start-up Aglaris Cell is close to launching onto the market the world's first bioreactor that cultures cell in a fully automated way, without using toxic additives. The device has attracted interest from the University of Oxford and the pharmaceutical giant, Merk.
Can young blood rejuvenate old bodies?
The transfusion of blood or blood components is not new. In fact, the first successful blood transfusion was performed by physician Richard Lower in 1665 in England. Blood transfusions have long been recognized for saving lives, but recently several studies indicate that blood may also be the key to regaining youth. Researchers report that blood obtained from healthy young adults has the potential to rejuvenate adults suffering from age-related degenerative processes, including cognitive decline.